Events Search and Views Navigation
May 2020
Webinar: CSL Behring Presents “COAG Patient and Provider Resource Overview”
Objectives: Discuss CSL Behring’s Commitment to Coagulation, Review of CSL Behring and Coagulation Patient Services, Provide Overview of CSL Behring’s Field Personnel. Audience: All HTC staff members.
Find out more »June 2020
Webinar: CSL Behring Presents “HUMATE-P, A clinical Overview”
Objectives: A clinical Case Study, How to Diagnose VWD, Types of VWD. Target Audience: HTC staff.
Find out more »Sanofi Genzyme Overview and Current Events Updates
Objectives: Rare Blood Disorder Pipeline Update, Patient Services Program Overview. Target Audience: HTC staff.
Find out more »Webinar: Takeda Presents “VONVENDI, The One and Only Recombinant von Willebrand Factor”
Examine important considerations in adults with con Willebrand disease (VWD) for on-demand treatment and control of bleeding episodes; discuss adult patient case studies in which VONVENDI may be appropriate. Target audience: Prescribers and nurses (including non-prescribing nurses).
Find out more »July 2020
2020 VIRTUAL HILL DAY
We are excited to be planning a virtual Hill Day for the Hemophilia Alliance so Alliance members and their patients can advocate for the bleeding disorders community from home.
Find out more »Webinar: Takeda Presents “Takeda Hematology Pipeline and Ongoing Clinical Trials”
Objectives: Answer request from Hemophilia Alliance to Share public information about Takeda hematology pipeline. Target Audience: Benign hematologists, treaters at Hemophilia Treating Centers and HCPs affiliated with Hemophilia Alliance.
Find out more »August 2020
NHF Bleeding Disorders Virtual Conference 2020
NHF’s 72nd Bleeding Disorders Conference (Virtual).
Find out more »HFA Symposium is going VIRTUAL!
HFA’s Symposium is an annual community-centered educational event that draws hundreds of members from the bleeding disorders community together to share information, learn new advancements and build a network of support!
Find out more »September 2020
Takeda Presents: Takeda Hematology Advate and Adynovate
Objectives: A patient case-based approach; Target Audience: HTC staff who work with Hem A patients who need to manage a more active lifestyle and may be interested in personalization
Find out more »New HTC Staff Meeting
Click the "Find Out More” button to register.
Find out more »